Peptovia Research
Access Verification Required

Research Professionals Only

Products on this site are intended exclusively for in vitro research.

By entering you agree to our terms of sale and use policy.

Research Use OnlyFree Shipping Over £100
Profiles

KPV: Research Profile

The C-terminal tripeptide of α-melanocyte-stimulating hormone (Lys-Pro-Val), studied in preclinical inflammation and mucosal-biology research.

4 min read·10 September 2026

What KPV is

KPV is a naturally occurring tripeptide corresponding to the C-terminal three residues of α-melanocyte-stimulating hormone (α-MSH). Its short sequence and small size have made it a convenient research tool for probing the anti-inflammatory activity that has been attributed to the C-terminus of α-MSH.

Molecular information

  • Sequence: Lys-Pro-Val (KPV)
  • Number of residues: 3
  • Approximate monoisotopic mass: ~342 Da (as the free acid)
  • Physical form: Typically supplied as a white lyophilised powder

Areas of published research

Preclinical research on KPV has examined its influence on inflammatory signalling in cell culture and in animal models of mucosal inflammation. As a very short peptide, KPV can be chromatographically challenging to retain on standard reversed-phase columns; ion-pairing agents or specialist method conditions may be required.

Analytical considerations

Standard research-peptide analytical checks apply: identity confirmation by mass spectrometry (see LC-MS peptide testing explained), purity assessment by reversed-phase HPLC at 214 nm (see what is HPLC peptide testing), and batch-specific documentation (see how to read a peptide COA). Refer to the Peptovia Research Certificate of Analysis page for live examples of the analytical format used for batches supplied.

Further reading

Peer-reviewed literature on KPV is accessible via PubMed and specialist journals. Readers are encouraged to evaluate primary sources directly rather than relying on secondary summaries.


Research Use Only. This profile is an educational overview of KPV as a research peptide. It does not describe or recommend human, veterinary or clinical use. Peptovia Research supplies KPV strictly for in-vitro laboratory research. No dosing, administration or therapeutic guidance is provided or implied.